0 Ratings

ID

14869

Description

Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193011

Link

https://clinicaltrials.gov/show/NCT00193011

Keywords

  1. 5/2/16 5/2/16 -
  2. 6/26/16 6/26/16 -
Uploaded on

May 2, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Breast Cancer NCT00193011

    Eligibility Breast Cancer NCT00193011

    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    to be included in this study, you must meet the following criteria:
    Description

    ID.1

    Data type

    boolean

    female patients with adenocarcinoma of the breast confirmed by biopsy
    Description

    ID.2

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0079399
    UMLS CUI [1,2]
    C0019638
    UMLS CUI [1,3]
    C0678222
    age 65 or older
    Description

    ID.3

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    under age 65 must have significant medical illness, or general frailty
    Description

    ID.4

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0205082
    UMLS CUI [1,2]
    C0221423|C0424594
    adequate bone marrow, liver or kidney function
    Description

    ID.5

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0005953
    UMLS CUI [1,2]
    C0232741
    UMLS CUI [1,3]
    C0232804
    normal heart function
    Description

    ID.6

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0232164
    less than 84 days from mastectomy/lumpectomy or axillary dissection
    Description

    ID.7

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C3714726
    signed consent obtained prior to initiation of any study procedures
    Description

    ID.8

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    you cannot participate in this study if any of the following apply to you:
    Description

    ID.9

    Data type

    boolean

    received neo-adjuvant therapy
    Description

    ID.10

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0600558
    primary tumor is locally advanced at diagnosis
    Description

    ID.11

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0205179
    UMLS CUI [1,2]
    C0678222
    received prior chemotherapy within five years
    Description

    ID.12

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1514457
    received previous radiation therapy within 5 years
    Description

    ID.13

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1522449
    peripheral neuropathy
    Description

    ID.14

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0031117
    please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
    Description

    ID.15

    Data type

    boolean

    Similar models

    Eligibility Breast Cancer NCT00193011

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    ID.1
    Item
    to be included in this study, you must meet the following criteria:
    boolean
    ID.2
    Item
    female patients with adenocarcinoma of the breast confirmed by biopsy
    boolean
    C0079399 (UMLS CUI [1,1])
    C0019638 (UMLS CUI [1,2])
    C0678222 (UMLS CUI [1,3])
    ID.3
    Item
    age 65 or older
    boolean
    C0001779 (UMLS CUI [1])
    ID.4
    Item
    under age 65 must have significant medical illness, or general frailty
    boolean
    C0205082 (UMLS CUI [1,1])
    C0221423|C0424594 (UMLS CUI [1,2])
    ID.5
    Item
    adequate bone marrow, liver or kidney function
    boolean
    C0005953 (UMLS CUI [1,1])
    C0232741 (UMLS CUI [1,2])
    C0232804 (UMLS CUI [1,3])
    ID.6
    Item
    normal heart function
    boolean
    C0232164 (UMLS CUI [1])
    ID.7
    Item
    less than 84 days from mastectomy/lumpectomy or axillary dissection
    boolean
    C3714726 (UMLS CUI [1])
    ID.8
    Item
    signed consent obtained prior to initiation of any study procedures
    boolean
    C0021430 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    ID.9
    Item
    you cannot participate in this study if any of the following apply to you:
    boolean
    ID.10
    Item
    received neo-adjuvant therapy
    boolean
    C0600558 (UMLS CUI [1])
    ID.11
    Item
    primary tumor is locally advanced at diagnosis
    boolean
    C0205179 (UMLS CUI [1,1])
    C0678222 (UMLS CUI [1,2])
    ID.12
    Item
    received prior chemotherapy within five years
    boolean
    C1514457 (UMLS CUI [1])
    ID.13
    Item
    received previous radiation therapy within 5 years
    boolean
    C1522449 (UMLS CUI [1])
    ID.14
    Item
    peripheral neuropathy
    boolean
    C0031117 (UMLS CUI [1])
    ID.15
    Item
    please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
    boolean

    Please use this form for feedback, questions and suggestions for improvements.

    Fields marked with * are required.

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial